Quantitative measurement of the histological features of alpha-1 antitrypsin deficiency-associated liver disease in biopsy specimens.
<h4>Background</h4>Pathological mutations in Alpha-1 Antitrypsin (AAT) protein cause retention of toxic polymers in the hepatocyte endoplasmic reticulum. The risk for cirrhosis in AAT deficiency is likely directly related to retention of these polymers within the liver. Polymers are clas...
Guardado en:
Autores principales: | George Marek, Amy Collinsworth, Chen Liu, Mark Brantly, Virginia Clark |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12ff8aa72c8747d68b904154ccd60fbf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
por: Caitriona McLean, et al.
Publicado: (2009) -
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Irina Petrache, et al.
Publicado: (2009) -
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives
por: Quinn M, et al.
Publicado: (2020) -
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
por: Alexa Núñez, et al.
Publicado: (2021) -
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
por: Dunlea DM, et al.
Publicado: (2018)